Osteocytic signalling pathways as therapeutic targets for bone fragility
A team of Northwestern investigators led by Peter Penzes, PhD, the Ruth and Evelyn Dunbar Professor of Psychiatry and Behavioral Sciences and director of the Center for Autism and Neurodevelopment, has developed a new therapy that could treat Phelan-McDermid syndrome, a subtype of autism spectrum disorder (ASD), according to findings published in Molecular Psychiatry
Research about potential prevention strategies, including the use of semaglutide, a drug used to treat type 2 diabetes and aid weight loss, is ongoing
Refund policy: 100 percent refund if not approved
A comprehensive medical evaluation is necessary to determine if Ozempic is an appropriate treatment option
Unfortunately, testosterone levels naturally decline with age